Skip to content
Supernus Pharmaceuticals Inc icon

Supernus Pharmaceuticals Inc

SUPNStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$46.50

Today

+77.8%

YTD

-6.2%

About

Supernus Pharmaceuticals Inc is a renowned pharmaceutical company that develops and commercialises products intended to treat central nervous system diseases. The company operates globally. Supernus Pharmaceuticals operates in the healthcare sector, specifically within the pharmaceutical industry. The company’s expertise lies in its unique product portfolio supporting neurological and psychiatric wellness. These engaging products have positioned Supernus as a distinguished entity within the pharmaceutical industry. The company is currently working on treatment for hypermobility in Parkinson’s disease, treatment-resistant depression and severe epilepsy. Diversify your virtual portfolio by following SUPN shares on eToro.

Price chart
Closing price history for SUPN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-54.80
P/S (TTM)2.88
P/B (TTM)2.30
Market cap$2.44B
Cap tierMid-cap
Industry avg P/E-17.91

Profitability

Gross margin76.00%
EBIT margin1.54%
Net margin9.22%
ROE-4.15%
ROA-3.11%

Earnings & Revenue

Revenue (TTM)$865.11M
Revenue growth (1Y)+26.9%
EPS (TTM)-$0.76
Free cash flow$86.96M
Total debt$36.20M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.52
Employees778
Next earnings25 Feb '27
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Supernus Pharmaceuticals Inc (SUPN) | Dirk Kuyken